Fort Worth

FortWorthWeekly.news — Western roots. Neighborhood news for modern Fort Worth.

Local business? Support local news on FortWorthWeekly.news

Back to Texas

Texas Secures $7.5 Million Settlement with Tris Pharma Over Pediatric ADHD Drug Marketing

State prosecutors finalized a resolution concluding allegations that the pharmaceutical manufacturer misled Medicaid providers regarding how quickly an ADHD medication acted for pediatric patients.

Sasha Esparza· AI-assisted, edited by Jake Team

October 2, 20261 min read

Pediatric healthcare settlement - illustration, Jake Team LLC

Fort Worth, Texas — State legal authorities concluded a $7.5 million financial resolution with Tris Pharmaceuticals, resolving allegations that the drugmaker defrauded the Texas Medicaid program by misrepresenting how quickly and effectively an attention-deficit medication worked for children.

The agreement concludes litigation initiated by state prosecutors in 2023 against the pharmaceutical manufacturer and corporate executive Ketan Mehta. State investigators alleged that the company orchestrated a deceptive promotional campaign concerning Dyanavel XR, an attention-deficit/hyperactivity disorder medication marketed for pediatric patients.

According to state enforcement filings, company sales representatives conducted thousands of promotional presentations to medical practitioners, including healthcare professionals enrolled in the state Medicaid network. Regulators asserted that sales representatives made unverified representations claiming the medication took effect far more rapidly than alternative therapies while providing additional clinical advantages that lacked scientific substantiation.

"Tris Pharma is now paying millions of dollars for misleading folks about ADHD drugs being prescribed to children." — Texas Attorney General Ken Paxton

Under the terms of the finalized agreement, the pharmaceutical manufacturer agreed to transfer $7.5 million to the state treasury to resolve the statutory claims, ending the enforcement action without further trial proceedings.

Across Fort Worth and Tarrant County, home to major children's medical networks and specialized pediatric clinics, the settlement reinforces clinical integrity across public assistance healthcare programs.

Sources: Office of the Texas Attorney General (October 2026): https://www.texasattorneygeneral.gov/news/releases/attorney-general-paxton-secures-75-million-settlement-tris-pharma-misrepresenting-efficacy-adhd-drug

Share

Sasha Esparza· AI-assisted, edited by Jake Team

Sasha Esparza writes about community life, schools, public safety, and local events in Fort Worth.

Related Stories

More in Sport

Sport

Chris Jimerson’s College Test Gets Longer at Tulane

Chris Jimerson Jr. scored through the air and on the ground in North Texas’ loss at UTSA. Tuesday’s starting announcement gives the Fort Worth native a full game to be judged as a quarterback rather than an emergency substitute.

Pierce NashNovember 18, 20264 min read
Sport

Prescott’s Five Touchdowns Met a Defense That Needed More

Dak Prescott’s late brilliance kept Dallas in range, but his third-quarter interception opened a 90-yard San Francisco drive that exposed why the Cowboys needed an almost perfect offensive afternoon.

Pierce NashNovember 16, 20263 min read